LCM
MBIO icon

Laurion Capital Management’s Mustang Bio MBIO Stock Holding History

Laurion Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,020
Closed -$317K – 593
2023
Q2 		$317K Sell
1,020
-907
-47% -$228K ﹤0.01% 448
2023
Q1 		$530K Hold
1,927
– – ﹤0.01% 334
2022
Q4 		$571K Hold
1,927
– – ﹤0.01% 350
2022
Q3 		$679K Hold
1,927
– – ﹤0.01% 387
2022
Q2 		$846K Buy
+1,927
New +$1.07M 0.01% 302

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.3B AUM 18.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Laurion Capital Management's MBIO Position: Q3 2023 in Review

Laurion Capital Management sold out of Mustang Bio (MBIO) in Q3 2023, closing a stake of 1,020 shares — an estimated $317K sold.

Laurion Capital Management first reported a position in MBIO in Q2 2022 and held it in 5 quarters. The position peaked at $846K in Q2 2022. 26 funds tracked by Wall St. Rank hold MBIO as of Q3 2023.

  • Laurion Capital Management reported no remaining Mustang Bio position as of Q3 2023 after selling out during the quarter.
  • Laurion Capital Management sold 1,020 Mustang Bio shares in Q3 2023, an estimated $317K.
  • Laurion Capital Management first reported a position in Mustang Bio in Q2 2022 and held it in 5 quarters.
  • Laurion Capital Management's Mustang Bio position peaked at $846K in Q2 2022.
  • 26 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2023.

Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.